- FOR IMMEDIATE RELEASE
- Contact: Rae Bazzarre The MACH 1 Group for Pelotonia (202) 320-5134 email@example.com
Pelotonia Announces Key Leadership Appointment
Miguel Perez named Vice President of Mission & Brand
COLUMBUS, OH (Mar. 13, 2017) – Today, Pelotonia, a grassroots organization that raises money to fund cancer research through its annual bike ride, announced the leadership appointment of Miguel Perez as Vice President of Mission & Brand. He begins his appointment on Mar. 16, 2017.
“Pelotonia is thrilled to appoint Miguel Perez as the first Vice President of Mission & Brand in our organization’s history,” said Doug Ulman, Pelotonia President and CEO. “Miguel has proven his dedication to serving the cancer community and helping those in need throughout his career. With his visionary leadership and experience with national and community-based organizations, we look forward to advancing our mission to end cancer and increasing support for the Pelotonia movement.”
“I’m excited, ready and feel very fortunate to join Pelotonia and continue serving a cause that’s very personal to me,” said Perez. “I have lost three siblings, other family members and many close friends to cancer. I hope to do everything I can to help Pelotonia realize its full potential as a leading philanthropic organization, and to reach our collective one goal!”
Perez will oversee the areas of communications and marketing, recruitment, community outreach and mission-related investments. He has extensive experience in philanthropy, business and non-profit management, including more than 15 years in higher executive management positions such as chief operating officer for the Dave Thomas Foundation for Adoption and managing account director for the branding agency Ologie. Prior to joining Pelotonia, he served in two executive roles with Dallas-based Susan G. Komen, the world’s largest non-profit source of funding for the fight against breast cancer. Perez, a graduate of The Ohio State University, is also the founder and president of the Vicki Speakman Memorial Fund, a non-profit he established in his sister’s honor in 2002 to support crucial breast cancer work, the disease that took her life.
Registration for Pelotonia ’17, which takes place Aug. 4-6, is now open at www.pelotonia.org. Pelotonia ’17 will hold its opening ceremony on Fri., Aug. 4. On Sat., Aug. 5, more than 7,500 riders will embark on 1- and 2-day rides on routes ranging from 25-180 miles and on Sun., Aug. 6, riders from the 130- and 180-mile routes will return to Columbus.
Pelotonia donates 100 percent of every rider-raised dollar directly to The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). These donations are used to support cancer research in several ways:
- Idea Grants, which investigate new and innovative basic, clinical, translation and population-based science clinical trials;
- Fellowships, which provide for undergraduate, graduate, medical and postdoctoral students to acquire state-of-the-art equipment and technologies;
- Funding research of the best and brightest physician scientists who are coming to Columbus, Ohio to further their passion for treating patients and pursuing scientific solutions.
Since its inception, Pelotonia has funded and awarded 99 idea grants and 405 fellowships as well as support for 79 senior scientists.
Founded in 2008, Pelotonia was established with the objective to fund life-saving cancer research. As a centerpiece of its year-round fundraising efforts, Pelotonia hosts a three-day experience that includes a weekend of cycling, entertainment and volunteerism. In its eight years, Pelotonia has raised over $130 million for cancer research. Thanks to its generous funding partners, Huntington Bank, L Brands Foundation, Peggy and Richard Santulli, American Electric Power Foundation, Nationwide, Cardinal Health Foundation, and Harold C. Schott Foundation, Pelotonia is able to direct 100 percent of every dollar raised by its participants to cancer research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. For more information, visit www.pelotonia.org.
About the OSUCCC – James
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 46 National Cancer Institute-designated Comprehensive Cancer Centers and one of only four centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anti-cancer drugs. As the cancer program’s 308-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet designation, the highest honor an organization can receive for quality patient care and professional nursing practice. At 21 floors with more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. For more information, visit cancer.osu.edu.